retatrutide nasal spray Ryaltris FDA Approves Ryaltris (mometasone and

Suggested dosage: 500 mg daily from supplements

In the STEP 2 trial, adults with obesity or overweight plus type 2 diabetes lost a mean 9.6% of their body weight at 68 weeks with semaglutide 2.4 mg vs

The GLP-1 Receptor Agonist (GLP-1 RA) medications, also referred to as incretin mimetics or GLP-1 analogs, are biochemical variations of naturally occurring GLP-1 altered for enhanced potency and stability that activate GLP-1 receptors and mimic GLP-1 effects throughout the body

Moving beyond food noise to drug noise, GLP-1s are quieting the roar of addiction. Reference: Metabolic medicines and addiction: what GLP-1 receptor agonists might add to substance use care by Fares Qeadan, 4 March 2026, BMJ

Limitations of the study However, the study warns that it has several limitations

Human No human studies regarding the safety of GLP-1 agonists during lactation were found